Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted therapies for soft-tissue sarcomas.

William D Tap1, Noah Federman, Fritz C Eilber

  • 1UCLA Sarcoma Program, Division of Hematology/Oncology, Los Angeles, CA 90095-7059, USA. wtap@mednet.ucla.edu

Expert Review of Anticancer Therapy
|May 12, 2007
PubMed
Summary

Developing effective treatments for rare soft-tissue sarcomas remains challenging. Advances in molecular biology are improving our understanding and leading to new therapeutic options for these complex cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials.

Cancer medicine·2026
Same author

Excellent Outcomes With High-Risk Pediatric Hepatoblastoma: A Detailed Analysis of a Large, Single-Center Experience.

Pediatric transplantation·2026
Same author

Multiple incomplete surgical and procedural interventions correlate with hyperprogression of a pleomorphic dermal sarcoma - a case report.

Journal of surgical case reports·2026
Same author

An international framework for clinical translation of molecular classifiers in osteosarcoma.

NPJ precision oncology·2026
Same author

Small bowel GIST harboring concurrent KIT exon 9 duplication and SDHC mutation: A case report.

Oncotarget·2026
Same author

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Area of Science:

  • Oncology
  • Translational Research
  • Molecular Biology

Background:

  • Soft-tissue sarcomas are rare and heterogeneous malignancies presenting significant therapeutic challenges.
  • Despite difficulties, scientific and clinical efforts have led to notable advances.
  • The molecular era of cancer research is beginning to elucidate the underlying biology of these tumors.

Purpose of the Study:

  • To review current therapeutic strategies for soft-tissue sarcomas.
  • To highlight agents that have progressed to clinical testing.
  • To emphasize the need for integrated research approaches.

Main Methods:

  • Review of current literature on soft-tissue sarcoma therapeutics.
  • Analysis of agents that have undergone clinical trials.

Related Experiment Videos

  • Discussion of challenges and future directions in treatment development.

    • Main Results:

    • Significant advances have been made in understanding soft-tissue sarcoma biology.
    • New therapeutic targets are emerging from molecular research.
    • Several novel compounds are currently in clinical testing.

    Conclusions:

    • Continued integration of past lessons with future promise is crucial for advancing soft-tissue sarcoma treatment.
    • Translational research is essential to develop and test novel compounds effectively.
    • Improving therapeutic options requires a concerted effort from the scientific and medical community.